Merriman Wealth Management, LLC Amgen Inc Transaction History

Merriman Wealth Management, LLC

$2.36 Billion
Q3 2024

A detailed history of Merriman Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 1,763 shares of AMGN stock, worth $464,338. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,763

Previous 1,873 5.87%

Holding current value

$464,338

Previous $585,000 2.91%

% of portfolio

0.02%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $34,031 - $37,111	-110 Reduced 5.87%	1,763 $568,000
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $26,275 - $31,931	100 Added 5.64%	1,873 $585,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $47,321 - $57,122	176 Added 11.02%	1,773 $504,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $10,495 - $13,030	-48 Reduced 2.92%	1,597 $429,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2,571 - $3,040	-12 Reduced 0.72%	1,645 $365,000
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $3,386 - $4,128	-15 Reduced 0.9%	1,657 $400,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $36,644 - $46,561	-160 Reduced 8.73%	1,672 $439,000
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $7,152 - $7,958	31 Added 1.72%	1,832 $445,000
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $47,581 - $52,637	-217 Reduced 10.75%	1,801 $436,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $98,644 - $112,889	496 Added 32.59%	2,018 $454,000
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $1,789 - $2,048	-9 Reduced 0.59%	1,522 $371,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $1,910 - $2,238	9 Added 0.59%	1,531 $326,000
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $28,963 - $32,133	-124 Reduced 7.53%	1,522 $371,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $13,092 - $15,257	-59 Reduced 3.46%	1,646 $410,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $54,527 - $64,932	252 Added 17.34%	1,705 $392,000
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $4,693 - $5,219	-20 Reduced 1.36%	1,453 $369,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $48,859 - $59,956	-247 Reduced 14.36%	1,473 $347,000
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $313,452 - $415,724	1,720 New	1,720 $349,000
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $199,039 - $233,319	-1,194 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $23.5 Million - $26.5 Million	-130,086 Reduced 99.09%	1,194 $227,000
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $254,576 - $297,172	-1,427 Reduced 1.08%	131,280 $25.7 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $22,975 - $25,902	-124 Reduced 0.09%	132,707 $27.5 Million
Q1 2018 Apr 10, 2018	SELL	$169.43 - $198.0 $248,384 - $290,268	-1,466 Reduced 1.09%	132,831 $22.6 Million
Q4 2017 Feb 05, 2018	SELL	$168.79 - $188.59 $2.18 Million - $2.43 Million	-12,892 Reduced 8.76%	134,297 $23.4 Million
Q3 2017 Oct 19, 2017	SELL	$167.29 - $191.0 $16,561 - $18,909	-99 Reduced 0.07%	147,189 $27.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	147,288	147,288 $25.4 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.

Account

Merriman Wealth Management, LLC Amgen Inc Transaction History